Filing metadata

Accession number
0000950170-25-111992
Form type
Form 4
Filer
BridgeBio Oncology Therapeutics, Inc.
CIK
CIK 1869105
Filed
Aug 28, 2025
Reporting period
Aug 26, 2025
Description
Insider transaction

Explore SEC Filings Hub